Literature DB >> 26447165

Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery.

Wiktor Kuliczkowski1, Joanna Sliwka2, Jacek Kaczmarski2, Dorota Zysko3, Michal Zembala2, Damian Steter2, Marian Zembala2, Seth Fortmann4, Victor Serebruany4.   

Abstract

BACKGROUND: Predicting bleeding events in patients with coronary artery bypass grafting (CABG) represents an unmet medical need that may improve CABG outcomes. HYPOTESIS: To assess the potential link between platelet function testing and bleeding risk in patients undergoing CABG.
METHODS: Platelet aggregation and clinical outcomes in 478 patients treated with aspirin and/or clopidogrel were retrospectively analyzed. Platelet activity was assessed prior to CABG with arachidonic acid (ASPI Test), and adenosine diphosphate(ADP Test) utilizing multiple-electrode aggregometry.
RESULTS: In the study group of 478 patients, mean age was 65.2±15.2 years; 138 were women. The majority of patients (n = 198) underwent on-pump surgery, with 162 undergoing off-pump and 30 undergoing minimally invasive surgery. Forty-eight patients received artificial valve implantation alone, and 40 received valve implantation in combination with CABG. The analysis of the entire pool revealed that an ASPI test value <407 area under curve per minute (AUC*min) may be useful in predicting postoperative drainage. In CABG patients only, an ASPI test value <271 AUC*min predicted the need for red blood cell concentrate transfusion following surgery. In patients who stopped clopidogrel for up to 5 days before surgery, the ADP test failed to exhibit prognostic utility for predicting bleeding risk.
CONCLUSIONS: In patients undergoing heart surgery, an ASPI test value <407 AUC*min may predict higher postoperative drainage, whereas <271 AUC*min may be linked to postoperative use of red blood cell concentrate.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26447165      PMCID: PMC6490720          DOI: 10.1002/clc.22472

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  15 in total

1.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Authors:  Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce Whitney Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak
Journal:  Circulation       Date:  2004-10-05       Impact factor: 29.690

2.  The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).

Authors:  Victor A Ferraris; Suellen P Ferraris; David J Moliterno; Philip Camp; Jeanine M Walenga; Harry L Messmore; Walter P Jeske; Fred H Edwards; David Royston; David M Shahian; Eric Peterson; Charles R Bridges; George Despotis
Journal:  Ann Thorac Surg       Date:  2005-04       Impact factor: 4.330

Review 3.  Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review.

Authors:  Marcel M C Hovens; Jaapjan D Snoep; Jeroen C J Eikenboom; Johanna G van der Bom; Bart J A Mertens; Menno V Huisman
Journal:  Am Heart J       Date:  2007-02       Impact factor: 4.749

4.  Effect of blood transfusion on long-term survival after cardiac operation.

Authors:  Milo C Engoren; Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

Review 5.  Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery.

Authors:  Christopher P Cannon; Shamir R Mehta; Sary F Aranki
Journal:  Ann Thorac Surg       Date:  2005-08       Impact factor: 4.330

6.  Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry.

Authors:  N Rahe-Meyer; M Winterhalter; A Boden; C Froemke; S Piepenbrock; A Calatzis; C Solomon
Journal:  Acta Anaesthesiol Scand       Date:  2009-02       Impact factor: 2.105

7.  Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

Authors:  Dirk Sibbing; Siegmund Braun; Tanja Morath; Julinda Mehilli; Wolfgang Vogt; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Journal:  J Am Coll Cardiol       Date:  2009-03-10       Impact factor: 24.094

8.  Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass?

Authors:  M Fattorutto; O Pradier; D Schmartz; B Ickx; L Barvais
Journal:  Br J Anaesth       Date:  2003-05       Impact factor: 9.166

Review 9.  Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

Authors:  Jaapjan D Snoep; Marcel M C Hovens; Jeroen C J Eikenboom; Johanna G van der Bom; J Wouter Jukema; Menno V Huisman
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749

10.  Aspirin and mortality from coronary bypass surgery.

Authors:  Dennis T Mangano
Journal:  N Engl J Med       Date:  2002-10-24       Impact factor: 91.245

View more
  2 in total

1.  CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary Interventions.

Authors:  Junghee Bang; Sun Young Choi; Moo Hyun Kim; Victor Serebruany
Journal:  EBioMedicine       Date:  2017-06-01       Impact factor: 8.143

2.  Big data modeling to predict platelet usage and minimize wastage in a tertiary care system.

Authors:  Leying Guan; Xiaoying Tian; Saurabh Gombar; Allison J Zemek; Gomathi Krishnan; Robert Scott; Balasubramanian Narasimhan; Robert J Tibshirani; Tho D Pham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.